Farmas USA

CELG

con sus gaps

ARNA

Era una coña. Yo estoy como tú.

Mi primera compra a 12 pavos. Los hay imbeciles y luego yo...

Si le sacamos algo a ésta, entonces si que me empezaré a creer que nada es imposible.

ARNA

...más bien, eran unas palabritas feas para CELG...

ARNA

Del Osborne:

Arena Jumps On Positive Clinical Trial Results

CEO Amit Munshi seemed to indicate that Arena intends to proceed without a partner. While this is possible, I believe that it is also plausible that such rhetoric could be a way to sweeten the amount on any potential offers. With its cash reserves, Arena can certainly afford to be patient and diligent about the prospects of potential partnering or a sale.

The company anticipates announcing several pipeline developments during 2018.

Celgene bought Recptos for over $7 billion two years ago to acquire Ozanimod.

I expect the stock to run up toward 52-week highs in the near term and anticipate that the outlook for another readout in Q2 will continue the positive trends.

https://seekingalpha.com/article/4157717-arena-jumps-positive-clinical-trial-results?app=1&auth_param=7ib4d:1db1th0:2f232e095443006d45cb6e451ca53eb9&uprof=44

SGYP

Nuevo artículo en SA. Prescindible. Resumen: ese management no nos lleva a ningún lado, que vendan de una puta vez. Y suerte que dice que va largo.

https://seekingalpha.com/article/4157725-synergy-illusion-success-grounded-potential-swot-analysis

MLNT

Añado a 10,30. Posición completada, media 10,50

KERX

Dentro 4,14